vvDD-hIL2-2-RG-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for vvDD-hIL2-2-RG-1, covering 2025-06-03 to 2025-06-03. Get the full timeline:
Most recent: Clinical Trial Update: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors [Phase 1]